X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5217) 5217
science & technology (4215) 4215
life sciences & biomedicine (4141) 4141
female (3644) 3644
middle aged (3451) 3451
oncology (3237) 3237
aged (3124) 3124
taxoids - administration & dosage (2921) 2921
male (2711) 2711
antineoplastic combined chemotherapy protocols - therapeutic use (2551) 2551
adult (2523) 2523
docetaxel (2371) 2371
taxoids - adverse effects (2101) 2101
antineoplastic combined chemotherapy protocols - adverse effects (1949) 1949
treatment outcome (1750) 1750
chemotherapy (1731) 1731
breast neoplasms - drug therapy (1594) 1594
cancer (1462) 1462
taxoids - therapeutic use (1429) 1429
drug administration schedule (941) 941
breast cancer (926) 926
disease-free survival (882) 882
taxoids (875) 875
aged, 80 and over (857) 857
antineoplastic agents - adverse effects (843) 843
care and treatment (829) 829
breast neoplasms - pathology (815) 815
lung neoplasms - drug therapy (813) 813
neoplasm staging (809) 809
antineoplastic agents - therapeutic use (794) 794
cisplatin - administration & dosage (782) 782
medicine & public health (769) 769
paclitaxel - adverse effects (745) 745
paclitaxel - administration & dosage (738) 738
paclitaxel - analogs & derivatives (730) 730
pharmacology & pharmacy (722) 722
antineoplastic combined chemotherapy protocols - administration & dosage (719) 719
carcinoma, non-small-cell lung - drug therapy (695) 695
deoxycytidine - analogs & derivatives (650) 650
fluorouracil - administration & dosage (629) 629
antineoplastic agents, phytogenic - adverse effects (595) 595
neoplasm metastasis (589) 589
research (563) 563
survival analysis (560) 560
survival rate (553) 553
deoxycytidine - administration & dosage (544) 544
metastasis (543) 543
retrospective studies (529) 529
antineoplastic agents - administration & dosage (520) 520
antineoplastic agents (519) 519
dose-response relationship, drug (519) 519
prostate cancer (517) 517
hematology, oncology and palliative medicine (483) 483
drug therapy (478) 478
prostatic neoplasms - drug therapy (478) 478
antimitotic agents (472) 472
neutropenia - chemically induced (472) 472
clinical trials (456) 456
antineoplastic agents, phytogenic - therapeutic use (453) 453
disease progression (414) 414
analysis (410) 410
prognosis (406) 406
lung neoplasms - pathology (396) 396
antineoplastic agents, phytogenic - administration & dosage (394) 394
paclitaxel - therapeutic use (394) 394
chemotherapy, adjuvant (372) 372
cancer research (369) 369
kaplan-meier estimate (367) 367
adenocarcinoma - drug therapy (365) 365
cisplatin - adverse effects (362) 362
neoplasms - drug therapy (358) 358
drug resistance, neoplasm (349) 349
carcinoma, non-small-cell lung - pathology (348) 348
animals (344) 344
follow-up studies (337) 337
infusions, intravenous (334) 334
stomach neoplasms - drug therapy (329) 329
cisplatin (327) 327
combined modality therapy (326) 326
prospective studies (325) 325
quality of life (321) 321
cyclophosphamide - administration & dosage (317) 317
oncology, experimental (308) 308
pharmacology/toxicology (308) 308
deoxycytidine - adverse effects (305) 305
fluorouracil - adverse effects (305) 305
health aspects (302) 302
carboplatin - administration & dosage (298) 298
doxorubicin - administration & dosage (292) 292
paclitaxel (285) 285
cancer therapies (280) 280
carcinoma, squamous cell - drug therapy (280) 280
toxicity (279) 279
cancer patients (278) 278
time factors (278) 278
capecitabine (272) 272
taxoids - pharmacology (272) 272
anthracyclines (262) 262
breast neoplasms - mortality (261) 261
neoadjuvant therapy (261) 261
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5017) 5017
Japanese (204) 204
Chinese (71) 71
German (52) 52
French (50) 50
Russian (18) 18
Italian (16) 16
Spanish (15) 15
Hungarian (8) 8
Polish (3) 3
Portuguese (3) 3
Czech (2) 2
Danish (2) 2
Lithuanian (2) 2
Dutch (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American Academy of Dermatology, ISSN 0190-9622, 2008, Volume 58, Issue 4, pp. 545 - 570
Journal Article
Annals of oncology, ISSN 0923-7534, 03/2018, Volume 29, Issue 3, pp. 646 - 653
Journal Article
The New England journal of medicine, ISSN 1533-4406, 06/2013, Volume 368, Issue 25, pp. 2385 - 2394
Journal Article
The Lancet (British edition), ISSN 0140-6736, 03/2016, Volume 387, Issue 10024, pp. 1163 - 1177
Summary Background Long-term hormone therapy has been the standard of care for advanced prostate cancer since the 1940s. STAMPEDE is a randomised controlled... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Survival analysis | Medical prognosis | Clinical trials | Hormone replacement therapy | Metastasis | Prostate cancer | Cancer therapies | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 01/2014, Volume 32, Issue 2, pp. 76 - 82
Journal Article
Annals of oncology, ISSN 0923-7534, 12/2012, Volume 23, Issue 12, pp. 3069 - 3074
Journal Article